Invivoscribe

Improving lives with precision diagnostics® for informed treatment decisions in myelo- and lympho-proliferative disorders. #Oncology #MFC #NGS #ClinicalTrials

[Invivoscribe @Invivoscribe]

Courage. Dedication. Selflessness. This #VeteransDay, we honor the men and women who have shown these qualities in service to our country. To all who have served and their families: thank you for your sacrifice.

#ThankYouVeterans #Invivoscribe #LabPMM

[Invivoscribe @Invivoscribe]

Tomorrow at #AMP2026: Where is MRD sensitivity determined? Join #Invivoscribe’s workshop on how standardized pre-analytics & the #PrepQuant™ System strengthen #MRD testing.

📅 Wed, Nov 11 | 4-5 PM📍 Tahoma 1, Level 3, Arch at 800 Pike
https://t.co/lGYgcjlmM5

#AML #ALL #KMT2A

[Invivoscribe @Invivoscribe]

AMP 2026 is almost here! 📊 We’re presenting 4 posters in Seattle on PrepQuant sample prep, FLT3/NPM1 MRD & LymphoTrack® Flex NGS.

🗓️ Fri 11/13 & Sat 11/14, 9:15 AM📍 Posters TT019, TT023, TT025, TT031

Visit us at booth #637!

#AMP2026 #Invivoscribe #sampleprep #UHSMRD

[Invivoscribe @Invivoscribe]

Is #MRD sensitivity set in the assay, or in sample prep? Join the #Invivoscribe workshop at #AMP2026 to see automated #gDNA/#cfDNA prep w/#PrepQuant™, plus high-sensitivity 𝘒𝘔𝘛2𝘈 detection for #MRD in #AML & ALL.

📅 Wed 11/11, 4–5 PM📍 Tahoma 1, Level 3 | Booth #637

[Invivoscribe @Invivoscribe]

Rigid #DNA input needs can rule out samples before testing. #LymphoTrack® Flex accepts 50–200ng for #clonality & #MRD across #IGHV Leader, IGH FR1/2/3, IGK, TRG & TRB, sensitivity scales w/input. https://t.co/NL8g4U5Cwn
Research Use Only. #Invivoscribe #NGS #MolecularDiagnostics

[Invivoscribe @Invivoscribe]

Heading to #AMP2026 in Seattle? Visit booth #637 to see automated sample prep meet ultrasensitive #MRD testing for #AML, #CLL, #ALL, #lymphoma & #myeloma.

🧬 PrepQuant System
🧬 LymphoTrack® Flex NGS
🧬 FLT3 ITD, NPM1 & KMT2A MRD

Book a meeting: https://t.co/S5c4RULqMV

[Invivoscribe @Invivoscribe]

Bring #NGS clonality testing in-house with results in under 50 hrs. Automation-ready #LymphoTrack® Flex multiplexes Ig & #TCR targets in one run for higher throughput. https://t.co/mOlmERPYnZ

For Research Use Only. Not for use in diagnostic procedures.

#Invivoscribe #Clonality

[Invivoscribe @Invivoscribe]

Last chance! Tomorrow, Oct 28, 10am PST | 1pm EST | 6pm CEST: Alice Scarpa on #NGS-based MRD & IG/TR repertoire insights post-transplant + Dr. Svea Stratmann on implementing UHS-NGS, from baseline clonotypes to longitudinal #MRD. #Invivoscribe

Register: https://t.co/CGtSbfptjK

[Invivoscribe @Invivoscribe]

Today is #MDSWorldAwarenessDay.

#MDS are rare blood cancers where bone marrow stops making healthy blood cells. Early signs like fatigue and bruising are often missed, and MDS can progress to #AML. Proud to stand with the MDS Alliance.

#BloodCancer #Invivoscribe

[Invivoscribe @Invivoscribe]

#Invivoscribe #NGS #MRD #MolecularPathology #Hematopathology #ALL #CLL #LymphoidMalignancies

[Invivoscribe @Invivoscribe]

How sensitive does your #MRD assay need to be? Wed, Oct 28, Dr. Svea Stratmann & Alice Scarpa share a lab-tested look at moving from PCR to UHS-NGS for clonality & MRD in ALL/CLL.
🗓️ 10am PST | 1pm EST | 6pm CEST

Register: https://t.co/Ckj69p2zc2
#Invivoscribe #NGS #MRD

[Invivoscribe @Invivoscribe]

#Clonality results shouldn’t depend on subjective interpretation. #LymphoTrack® Flex assays + software deliver standardized analysis & objective results across 7 Ig/TCR targets. https://t.co/ugwuLxCvQq For RUO Only. Not for use in diagnostic procedures. #Invivoscribe #NGS

[Invivoscribe @Invivoscribe]

Visiting #ASHG2026 in Montréal? Stop by the #Invivoscribe poster: LymphoTrack® Enterprise Software for quantitative MRD, CLL subset classification & Ig/TCR repertoire diversity.

📆 Wed, Oct 21, 2:30 PM📍 Board 2032W

#MRD #CLL #ImmuneRepertoire #NGS #Bioinformatics

[Invivoscribe @Invivoscribe]

Moving from PCR to #NGS for #MRD changes how you validate, set your limit of detection & choose clonal markers. Our webinar gives labs a realistic roadmap. 📅 Oct 28 | 10am PT / 1pm ET / 6pm CEST Register: https://t.co/nogtAknKfi

#Invivoscribe #ClonalityTesting #Hematology

[Invivoscribe @Invivoscribe]

Heading to #ASHG2026 in Montréal? Catch the #Invivoscribe poster on #LymphoTrack® Enterprise Software: automated, high-throughput analysis for B- & T-cell #NGS clonality, incl. quantitative MRD & CLL subsets. 📆Wed, Oct 21, 2:30 PM📍Board 2032W, Poster Hall
#PrecisionDiagnostics

[Invivoscribe @Invivoscribe]

Introducing LymphoTrack® Flex: bring clonality, SHM & ultra-high sensitivity NGS testing in-house. Flexible DNA input, scalable multiplexing, automation-ready, results in <50 hrs. More control, faster TAT, confident MRD detection.

https://t.co/KeDFbrmoEp

#NGS #MRD #Clonality

[Invivoscribe @Invivoscribe]

#MRD #AssociationfotMolecularPathology #sampleprep #UHSMRD

[Invivoscribe @Invivoscribe]

#Invivoscribe is heading to Seattle for #AMP2026!

📍 Booth #637: sample prep to ultra-high sensitivity MRD
⚙️ Workshop: Wed 11/11, 4–5 PM, Tahoma 1,
📊 Posters TT023 (Fri 11/13), TT019, TT025, TT031 (Sat 11/14), 9:15 AM

We can't wait to see you in Seattle!

[Invivoscribe @Invivoscribe]

Is your lab ready to move beyond PCR? Join Dr. Svea Stratmann & Alice Scarpa on Oct 28 (10am PT | 1pm ET) for A Practical Path to NGS: Clonality & Ultra-High Sensitivity MRD in Lymphoid Malignancies.

Register: https://t.co/9CpAEKyZAW

#NGS #MRD #Hematopathology #Invivoscribe

[Invivoscribe @Invivoscribe]

That's a wrap on #ICCS2026! Thanks to all who visited booth #405 in Miami and to Dr. Hong Drum of #LabPMM for joining us. Missed us? Explore our standardized MFC assays for heme screening, AML MRD & CLL MRD: https://t.co/8W8wjBFQIR

#FlowCytometry #MRD #Invivoscribe